학술논문
Prognostic interaction between thrombocytosis and JAK2 V617F mutation in the WHO subcategories of myelodysplastic/myeloproliferative disease-unclassifiable and refractory anemia with ringed sideroblasts and marked thrombocytosis.
Document Type
Letter
Author
Source
Subject
*LETTERS to the editor
*MYELOPROLIFERATIVE neoplasms
*ANEMIA
*GENETIC mutation
*MYELODYSPLASTIC syndromes
*PROGNOSIS
*PROTEINS
*SURVIVAL
*THROMBOCYTOSIS
*
*
*
*
*
*
*
*
Language
ISSN
0887-6924
Abstract
A letter to the editor is presented in response to the article "Prognostic Interaction Between Thrombocytosis and JAK2 V617F Mutation in the WHO Subcategories of Myelodysplastic/Myeloproliferative Disease-Unclassifiable and Refractory Anemia With Ringed Sideroblasts and Marked Thrombocytosis," in the December 6, 2007 issue.